This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Cline Scientific マネジメント

マネジメント基準チェック /24

Cline Scientific'sの CEO はAnders Sundhで、 Jan2012年に任命され、の在任期間は 12.42年です。は、会社の株式の15.32%を直接所有しており、その価値はSEK 689.71K 。経営陣と取締役会の平均在任期間はそれぞれ5.4年と4.4年です。

主要情報

Anders Sundh

最高経営責任者

n/a

報酬総額

CEO給与比率	n/a
CEO在任期間	12.6yrs
CEOの所有権	15.3%
経営陣の平均在職期間	5.6yrs
取締役会の平均在任期間	3.6yrs

経営陣の近況

Recent updates

CEO（最高経営責任者

Anders Sundh

12.6yrs

在職期間

Mr. Anders Patrik Sundh is a Co-Founder and serves as the Chief Executive Officer and President at Cline Scientific AB. He serves as a Director of Cline Scientific AB (publ) since May 2018. He has the Life...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Anders Sundh	Co-Founder	12.6yrs	データなし	15.32% SEK 475.9k
Håkan Bengtsson	Chief Financial Officer	6.6yrs	データなし	データなし
Victoria Bicknell	Communications Manager	4.6yrs	データなし	データなし
Hanne Evenbratt	VP of Research & Development and Director	less than a year	データなし	データなし

5.6yrs

平均在職期間

経験豊富な経営陣: CLINE Bの経営陣は経験豊富で経験豊富です（平均在職期間は5.4年）。

取締役

名称	ポジション	在職期間	報酬	所有権
Anders Sundh	Co-Founder	6.3yrs	データなし	15.32% SEK 475.9k
Hanne Evenbratt	VP of Research & Development and Director	1.6yrs	データなし	データなし
Peter von Ehrenheim	Member of Advisory Board	no data	データなし	データなし
Mattias Berglin	Member of Scientific Advisory Board	no data	データなし	データなし
Anders Lundgren	Member of Scientific Advisory Board	no data	データなし	データなし
Stephen Minger	Member of Board of Scientific Advisors	5.6yrs	データなし	データなし
Mats Brittberg	Member of Advisory Board	no data	データなし	データなし
Sven Grekevik	Member of Advisory Board	no data	データなし	データなし
Michael Andang	Member of Scientific Advisory Board	no data	データなし	データなし
Theresa Vincent	Member of Scientific Advisory Board	no data	データなし	データなし
Petra Szeszula	Member of Advisory Board	no data	データなし	データなし
Karl Corneliusson	Independent Chairman	1.6yrs	データなし	データなし

3.6yrs

平均在職期間

57yo

平均年齢

経験豊富なボード: CLINE Bの取締役会は経験豊富であると考えられます ( 4.4年の平均在任期間)。

This company listing is no longer active

Cline Scientific マネジメント

マネジメント 基準チェック /24

主要情報

経営陣の近況

Cline Scientific AB (Publ) Announces Board Changes

Cline Scientific AB (Publ) Announces Board Changes

Cline Scientific AB (publ)Announces Executive Changes

Less than half of directors are independent

Less than half of directors are independent

Cline Scientific Appoints Lars Peterson as New Advisor

Recent updates

Cline Scientific AB (Publ) Announces Board Changes

Cline Scientific AB (Publ) Announces Board Changes

Full year 2023 earnings released

New major risk - Revenue and earnings growth

Cline Scientific AB (publ)Announces Executive Changes

New major risk - Shareholder dilution

Cline Scientific AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 6.177231 million.

Cline Scientific AB (publ) Announces European Method Patent for Providing A Cartilage Implant with Chondrocytes

Less than half of directors are independent

Full year 2022 earnings released

Cline Scientific AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 21.528346 million.

Cline Scientific AB (publ) Announces Successful Results Gained During Ex-Vivo Testing Project for Cline Scientific's StemCART Project

First half 2022 earnings released: EPS: kr0 (vs kr0.22 loss in 1H 2021)

Cline Scientific AB Submits China Patent Application for StemCART Product

Cline Scientific AB (Publ) Provides an Update on Current StemCART Exvivo Testing Project

Less than half of directors are independent

Cline Scientific AB (publ) Announces Successfully Completes First Stage of StemCART Ex-Vivo Testing on Human Cartilage

Cline Scientific AB Successfully Completes First Stage of StemCART Ex-Vivo Testing on Human Cartilage

Full year 2021 earnings: Revenues in line with analyst expectations

Cline Scientific Appoints Lars Peterson as New Advisor

Cline Receives Clearance for Ex-Vivo Testing of StemCART Product on Human Cartilage Tissue

Chalmers University Master’s Student Project Concludes with Successful Development of StemCART Matrix

Cline Scientific AB Provides Updates on StemCART Project

First quarter 2021 earnings released

Cline Scientific AB (publ) Files New Patent Application for CellRACE Cancer Diagnostic Product

Cline Submits International Patent Application for StemCART Therapy Product

Cline Scientific Initiates Collaboration with Global Biopharmaceutical Company with the Aim of Uncovering Core Mechanisms of Vascular Disease

New 90-day low: kr2.70

New 90-day low: kr3.00

New 90-day low: kr3.10

Earnings released

New 90-day high - kr4.24

CEO（最高経営責任者

在職期間

リーダーシップ・チーム

平均在職期間

取締役

平均在職期間

平均年齢

マネジメント基準チェック /24